Adagio Medical (ADGM) Explodes 83% on Clinical Breakthrough: Is the Ultrasound Rally Just Beginning?

Summary

• Adagio Medical Holdings (ADGM) surged 83.61% to $0.8446 in a massive intraday move.

• The stock hit an intraday high of $1.13, driven by first-patient treatment news for its ULTA system.

• Turnover exploded to over $458 million with a staggering 2101% turnover rate, signaling intense speculative interest.

• The company submitted a PMA application to the FDA in May 2026, advancing its regulatory timeline for the vCLAS system.

Adagio Medical has captured the market's attention with a violent upward spike, transforming a micro-cap into a high-volume trading vehicle. The catalyst is clear: investor excitement over the first patient treated with the faster, single-freeze ULTA ventricular ablation platform under Expanded Access. This clinical milestone, combined with a robust regulatory submission history, has triggered a momentum surge that far outpaces broader market trends.